Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
86.65
-0.82 (-0.94%)
At close: Jul 15, 2026, 4:00 PM EDT
87.00
+0.35 (0.40%)
Pre-market: Jul 16, 2026, 5:12 AM EDT
Oruka Therapeutics Employees
Oruka Therapeutics had 68 employees as of December 31, 2025. The number of employees increased by 40 or 142.86% compared to the previous year.
Employees
68
Change (1Y)
40
Growth (1Y)
142.86%
Revenue / Employee
n/a
Profits / Employee
-$1,385,147
Market Cap
5.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | 40 | 142.86% |
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| ACADIA Pharmaceuticals | 798 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Celcuity | 155 |
| Definium Therapeutics | 106 |
| Dianthus Therapeutics | 92 |
ORKA News
- 13 days ago - Oruka Therapeutics falls -8.1% - TheFly
- 15 days ago - Oruka Therapeutics price target raised to $130 from $100 at UBS - TheFly
- 6 weeks ago - Oruka Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Oruka Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Oruka Therapeutics reports Q1 EPS (48c), consensus (54c) - TheFly
- 2 months ago - Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Oruka Therapeutics Quarterly report: Q1 2026 - Filings